Add to ORKGN gonorrhoeae stem from basic research on the biology of the organism, the development of diagnostic capabilities, and the availability of more effective drugs. The “bench to practise ” trans-lation of this research is vital to building capacity. This presentation will focus on the gonorrhoea resistance research and training opportunities to contribute to the prevention and control efforts
CDC is providing critical support to combat antibiotic- resistant bacteria by updating treatment gui...
antimicrobial resistance and decreasing culture capacity, molecular assays capable of detecting exte...
The successful treatment of gonorrhea, presently the second most prevalent bac-terial sexually trans...
Prevention and control of gonorrhea is an important public health concern due to the high burden of ...
Gonorrhea is a sexually transmitted disease with a high morbidity burden. Incidence of this disease ...
Gonorrhea is a sexually transmitted disease with a high morbidity burden. Incidence of this disease ...
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i>: Global surveillance and a call for interna...
Neisseria gonorrhoeae is the second most common bacterial sexually transmitted infection in the worl...
Drug-resistant Neisseria gonorrhoeae poses a significant public health challenge. In recent years, g...
Neisseria gonorrhoeae (N. gonorrhoeae) is the etiological agent of the second most common sexually t...
Neisseria gonorrhoeae is one of the most frequent etiologic agents of STDs (sexually transmitted dis...
With the increasing resistance worldwide of Neisseria gonorrhoeae to antibiotics, new treatment opti...
The goal of the Sexually Transmitted Infection Clinical Trial Group's Antimicrobial Resistance (AMR)...
Monitoring trends in antimicrobial drug–resistant Neisseria gonorrhoeae is a critical public health ...
In a Perspective on the research article by Didelot and colleagues, Magnus Unemo and Christian Altha...
CDC is providing critical support to combat antibiotic- resistant bacteria by updating treatment gui...
antimicrobial resistance and decreasing culture capacity, molecular assays capable of detecting exte...
The successful treatment of gonorrhea, presently the second most prevalent bac-terial sexually trans...
Prevention and control of gonorrhea is an important public health concern due to the high burden of ...
Gonorrhea is a sexually transmitted disease with a high morbidity burden. Incidence of this disease ...
Gonorrhea is a sexually transmitted disease with a high morbidity burden. Incidence of this disease ...
Antimicrobial resistance in <i>Neisseria gonorrhoeae</i>: Global surveillance and a call for interna...
Neisseria gonorrhoeae is the second most common bacterial sexually transmitted infection in the worl...
Drug-resistant Neisseria gonorrhoeae poses a significant public health challenge. In recent years, g...
Neisseria gonorrhoeae (N. gonorrhoeae) is the etiological agent of the second most common sexually t...
Neisseria gonorrhoeae is one of the most frequent etiologic agents of STDs (sexually transmitted dis...
With the increasing resistance worldwide of Neisseria gonorrhoeae to antibiotics, new treatment opti...
The goal of the Sexually Transmitted Infection Clinical Trial Group's Antimicrobial Resistance (AMR)...
Monitoring trends in antimicrobial drug–resistant Neisseria gonorrhoeae is a critical public health ...
In a Perspective on the research article by Didelot and colleagues, Magnus Unemo and Christian Altha...
CDC is providing critical support to combat antibiotic- resistant bacteria by updating treatment gui...
antimicrobial resistance and decreasing culture capacity, molecular assays capable of detecting exte...
The successful treatment of gonorrhea, presently the second most prevalent bac-terial sexually trans...